Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TVRD | AZN | AMGN | GILD | VRTX |
| Company | Tvardi Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.8600 | 187.07 | 362.63 | 127.28 | 502.71 |
| High | 1.9400 | 187.65 | 364.00 | 127.62 | 502.71 |
| Low | 1.8043 | 183.72 | 359.54 | 125.50 | 494.80 |
| Latest | 1.8701 | 184.60 | 358.79 | 126.29 | 499.20 |
| Change | -0.0299 | -5.02 | -3.33 | -0.05 | +2.47 |
| % Change | -1.57% | -2.65% | -0.92% | -0.04% | +0.50% |
| Volume | 69,628 | 993,078 | 482,809 | 1,216,732 | 255,640 |
| 20-Day Average Volume | 388,628 | 1,969,007 | 3,139,788 | 9,121,886 | 1,811,267 |
| Previous Close | 1.9000 | 189.62 | 362.12 | 126.34 | 496.73 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.5062 | 181.87 | 349.36 | 126.03 | 461.11 |
| 20-Day Raw Stochastic | 22.97% | 61.72% | 94.69% | 50.00% | 93.26% |
| 20-Day Relative Strength | 32.78 | 50.05 | 60.44 | 46.15 | 68.68 |
| Weighted Alpha | -56.59 | +23.96 | +21.71 | +8.05 | +16.30 |
| Today's Opinion | 100% Sell | 8% Sell | 56% Buy | 72% Sell | 72% Buy |
| Previous Opinion | 100% Sell | 8% Buy | 56% Buy | 56% Sell | 72% Buy |
| Last Month's Opinion | 64% Sell | 40% Sell | 40% Sell | 24% Sell | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -19.36% since 06/24/26 | +0.78% since 06/24/26 | +3.00% since 06/24/26 | +1.09% since 06/24/26 | +4.85% since 06/24/26 |
| Low | 1.5000 on 06/26/26 | 183.72 on 07/01/26 | 350.06 on 06/25/26 | 123.67 on 06/25/26 | 473.50 on 06/25/26 |
| High | 2.6499 on 06/25/26 | 191.13 on 06/29/26 | 364.00 on 07/01/26 | 128.86 on 06/29/26 | 503.89 on 06/26/26 |
| 1-Month | |||||
| %Chg | -41.15% since 06/01/26 | +2.63% since 06/01/26 | +9.98% since 06/01/26 | -3.49% since 06/01/26 | +13.65% since 06/01/26 |
| Low | 1.5000 on 06/26/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 3.2497 on 06/02/26 | 191.13 on 06/29/26 | 364.00 on 07/01/26 | 131.66 on 06/05/26 | 503.89 on 06/26/26 |
| 3-Month | |||||
| %Chg | -36.83% since 04/01/26 | -8.12% since 04/01/26 | +2.46% since 04/01/26 | -9.82% since 04/01/26 | +11.40% since 04/01/26 |
| Low | 1.5000 on 06/26/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 4.3399 on 05/07/26 | 207.30 on 04/10/26 | 364.00 on 07/01/26 | 142.97 on 04/09/26 | 503.89 on 06/26/26 |
| 6-Month | |||||
| %Chg | -55.93% since 12/31/25 | +0.32% since 12/31/25 | +10.59% since 12/31/25 | +3.08% since 12/31/25 | +9.90% since 12/31/25 |
| Low | 1.5000 on 06/26/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 4.8899 on 01/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 17,824 | 294,083,168 | 195,439,056 | 156,859,936 | 126,072,560 |
| Shares Outstanding, K | 9,381 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -18,210,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -6,800,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 0.33 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 05/08/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/13/26 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.62 | 16.31 | 15.09 | 29.71 |